A pregnancy test attempts to determine whether or not a woman is pregnant. Indicative markers are found in blood and urine, and pregnancy tests require sampling one of these substances. The first of these markers to be discovered, human chorionic gonadotropin (hCG), was discovered in 1930 to be produced by the syncytiotrophoblast cells of the fertilised ova (eggs).
Highlights
The global Pregnancy and Ovulation Testing market was valued at US$ 234360 million in 2022 and is anticipated to reach US$ 288090 million by 2029, witnessing a CAGR of 3.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The increasing acceptance of home testing kits to check the possibility of pregnancy is projected to spur market demand during the forecast period.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pregnancy and Ovulation Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pregnancy and Ovulation Testing.
The Pregnancy and Ovulation Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pregnancy and Ovulation Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pregnancy and Ovulation Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
SPD
Church & Dwight
BioMerieux
Abbott
Rohto
Mankind Pharma
Geratherm Medical
Fairhaven Health
Quidel Corporation
Wondfo
Arax
Egens Biotech
RunBio
CIGA Healthcare
Segment by Type
Pregnancy Testing
Ovulation Testing
Segment by Application
Fertility Centers
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pregnancy and Ovulation Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pregnancy and Ovulation Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Pregnancy Testing
1.2.3 Ovulation Testing
1.3 Market by Application
1.3.1 Global Pregnancy and Ovulation Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Fertility Centers
1.3.3 Hospitals
1.3.4 Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pregnancy and Ovulation Testing Market Perspective (2018-2029)
2.2 Pregnancy and Ovulation Testing Growth Trends by Region
2.2.1 Global Pregnancy and Ovulation Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pregnancy and Ovulation Testing Historic Market Size by Region (2018-2023)
2.2.3 Pregnancy and Ovulation Testing Forecasted Market Size by Region (2024-2029)
2.3 Pregnancy and Ovulation Testing Market Dynamics
2.3.1 Pregnancy and Ovulation Testing Industry Trends
2.3.2 Pregnancy and Ovulation Testing Market Drivers
2.3.3 Pregnancy and Ovulation Testing Market Challenges
2.3.4 Pregnancy and Ovulation Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pregnancy and Ovulation Testing Players by Revenue
3.1.1 Global Top Pregnancy and Ovulation Testing Players by Revenue (2018-2023)
3.1.2 Global Pregnancy and Ovulation Testing Revenue Market Share by Players (2018-2023)
3.2 Global Pregnancy and Ovulation Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pregnancy and Ovulation Testing Revenue
3.4 Global Pregnancy and Ovulation Testing Market Concentration Ratio
3.4.1 Global Pregnancy and Ovulation Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pregnancy and Ovulation Testing Revenue in 2022
3.5 Pregnancy and Ovulation Testing Key Players Head office and Area Served
3.6 Key Players Pregnancy and Ovulation Testing Product Solution and Service
3.7 Date of Enter into Pregnancy and Ovulation Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pregnancy and Ovulation Testing Breakdown Data by Type
4.1 Global Pregnancy and Ovulation Testing Historic Market Size by Type (2018-2023)
4.2 Global Pregnancy and Ovulation Testing Forecasted Market Size by Type (2024-2029)
5 Pregnancy and Ovulation Testing Breakdown Data by Application
5.1 Global Pregnancy and Ovulation Testing Historic Market Size by Application (2018-2023)
5.2 Global Pregnancy and Ovulation Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pregnancy and Ovulation Testing Market Size (2018-2029)
6.2 North America Pregnancy and Ovulation Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pregnancy and Ovulation Testing Market Size by Country (2018-2023)
6.4 North America Pregnancy and Ovulation Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pregnancy and Ovulation Testing Market Size (2018-2029)
7.2 Europe Pregnancy and Ovulation Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pregnancy and Ovulation Testing Market Size by Country (2018-2023)
7.4 Europe Pregnancy and Ovulation Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pregnancy and Ovulation Testing Market Size (2018-2029)
8.2 Asia-Pacific Pregnancy and Ovulation Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pregnancy and Ovulation Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Pregnancy and Ovulation Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pregnancy and Ovulation Testing Market Size (2018-2029)
9.2 Latin America Pregnancy and Ovulation Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pregnancy and Ovulation Testing Market Size by Country (2018-2023)
9.4 Latin America Pregnancy and Ovulation Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pregnancy and Ovulation Testing Market Size (2018-2029)
10.2 Middle East & Africa Pregnancy and Ovulation Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pregnancy and Ovulation Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Pregnancy and Ovulation Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 SPD
11.1.1 SPD Company Detail
11.1.2 SPD Business Overview
11.1.3 SPD Pregnancy and Ovulation Testing Introduction
11.1.4 SPD Revenue in Pregnancy and Ovulation Testing Business (2018-2023)
11.1.5 SPD Recent Development
11.2 Church & Dwight
11.2.1 Church & Dwight Company Detail
11.2.2 Church & Dwight Business Overview
11.2.3 Church & Dwight Pregnancy and Ovulation Testing Introduction
11.2.4 Church & Dwight Revenue in Pregnancy and Ovulation Testing Business (2018-2023)
11.2.5 Church & Dwight Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Detail
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Pregnancy and Ovulation Testing Introduction
11.3.4 BioMerieux Revenue in Pregnancy and Ovulation Testing Business (2018-2023)
11.3.5 BioMerieux Recent Development
11.4 Abbott
11.4.1 Abbott Company Detail
11.4.2 Abbott Business Overview
11.4.3 Abbott Pregnancy and Ovulation Testing Introduction
11.4.4 Abbott Revenue in Pregnancy and Ovulation Testing Business (2018-2023)
11.4.5 Abbott Recent Development
11.5 Rohto
11.5.1 Rohto Company Detail
11.5.2 Rohto Business Overview
11.5.3 Rohto Pregnancy and Ovulation Testing Introduction
11.5.4 Rohto Revenue in Pregnancy and Ovulation Testing Business (2018-2023)
11.5.5 Rohto Recent Development
11.6 Mankind Pharma
11.6.1 Mankind Pharma Company Detail
11.6.2 Mankind Pharma Business Overview
11.6.3 Mankind Pharma Pregnancy and Ovulation Testing Introduction
11.6.4 Mankind Pharma Revenue in Pregnancy and Ovulation Testing Business (2018-2023)
11.6.5 Mankind Pharma Recent Development
11.7 Geratherm Medical
11.7.1 Geratherm Medical Company Detail
11.7.2 Geratherm Medical Business Overview
11.7.3 Geratherm Medical Pregnancy and Ovulation Testing Introduction
11.7.4 Geratherm Medical Revenue in Pregnancy and Ovulation Testing Business (2018-2023)
11.7.5 Geratherm Medical Recent Development
11.8 Fairhaven Health
11.8.1 Fairhaven Health Company Detail
11.8.2 Fairhaven Health Business Overview
11.8.3 Fairhaven Health Pregnancy and Ovulation Testing Introduction
11.8.4 Fairhaven Health Revenue in Pregnancy and Ovulation Testing Business (2018-2023)
11.8.5 Fairhaven Health Recent Development
11.9 Quidel Corporation
11.9.1 Quidel Corporation Company Detail
11.9.2 Quidel Corporation Business Overview
11.9.3 Quidel Corporation Pregnancy and Ovulation Testing Introduction
11.9.4 Quidel Corporation Revenue in Pregnancy and Ovulation Testing Business (2018-2023)
11.9.5 Quidel Corporation Recent Development
11.10 Wondfo
11.10.1 Wondfo Company Detail
11.10.2 Wondfo Business Overview
11.10.3 Wondfo Pregnancy and Ovulation Testing Introduction
11.10.4 Wondfo Revenue in Pregnancy and Ovulation Testing Business (2018-2023)
11.10.5 Wondfo Recent Development
11.11 Arax
11.11.1 Arax Company Detail
11.11.2 Arax Business Overview
11.11.3 Arax Pregnancy and Ovulation Testing Introduction
11.11.4 Arax Revenue in Pregnancy and Ovulation Testing Business (2018-2023)
11.11.5 Arax Recent Development
11.12 Egens Biotech
11.12.1 Egens Biotech Company Detail
11.12.2 Egens Biotech Business Overview
11.12.3 Egens Biotech Pregnancy and Ovulation Testing Introduction
11.12.4 Egens Biotech Revenue in Pregnancy and Ovulation Testing Business (2018-2023)
11.12.5 Egens Biotech Recent Development
11.13 RunBio
11.13.1 RunBio Company Detail
11.13.2 RunBio Business Overview
11.13.3 RunBio Pregnancy and Ovulation Testing Introduction
11.13.4 RunBio Revenue in Pregnancy and Ovulation Testing Business (2018-2023)
11.13.5 RunBio Recent Development
11.14 CIGA Healthcare
11.14.1 CIGA Healthcare Company Detail
11.14.2 CIGA Healthcare Business Overview
11.14.3 CIGA Healthcare Pregnancy and Ovulation Testing Introduction
11.14.4 CIGA Healthcare Revenue in Pregnancy and Ovulation Testing Business (2018-2023)
11.14.5 CIGA Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
SPD
Church & Dwight
BioMerieux
Abbott
Rohto
Mankind Pharma
Geratherm Medical
Fairhaven Health
Quidel Corporation
Wondfo
Arax
Egens Biotech
RunBio
CIGA Healthcare
听
听
*If Applicable.
